| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.34 | 0.04 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |